Loading...
XCNQ
TRUE
, Last price  
CAD
Name

Treatment.com International Inc

Chart & performance

D1W1MN
XCNQ:TRUE chart
P/E
—
P/S
—
EPS
—
Vol. 1Y
—
Shs. 5Y
46.75%
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
11k
000000010,990
Net income
-8m
L+102.92%
-96,515-70,084-3,004,015-2,908,268-13,864,163-3,796,750-3,722,382-7,553,593
CFO
-4m
L+499.95%
-78,354-107,438-509,709-2,012,159-6,290,324-1,458,107-740,078-4,440,116

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Rocket Doctor AI is a pioneering company dedicated to enhancing the healthcare sector. They achieve this by strategically deploying advanced artificial intelligence alongside the highest clinical standards, effectively addressing existing inefficiencies and challenges within the industry. Through the collaborative efforts and global insights of hundreds of medical professionals, Rocket Doctor AI has developed the Global Library of Medicine (GLM). This sophisticated and personalized AI engine is specifically designed for healthcare applications. The GLM is fortified by over 10,000 meticulously reviewed expert medical analyses, offering validated clinical insights and comprehensive support to all healthcare providers. Its functionalities extend to recommending diagnostic procedures—encompassing physical examinations, laboratory tests, and imaging—as well as suggesting appropriate billing classifications. A primary goal of the GLM is to substantially reduce the administrative burdens faced by medical professionals, including physicians, nurses, and pharmacists.
IPO date
Apr 19, 2021
Employees
3
Domiciled in
US
Incorporated in
CA
Headquarters & legal address
800 - 885 West Georgia Street
Vancouver, BC V6C 3H1
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT